Cegedim S.A (CGM) | Financial Analysis & Statements
Cegedim S.A. Mid-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2016Income Metrics
Revenue
122.5M
Gross Profit
76.2M
62.17%
Operating Income
11.8M
9.64%
Net Income
-10.0M
-8.13%
Balance Sheet Metrics
Total Assets
986.9M
Total Liabilities
704.4M
Shareholders Equity
282.5M
Debt to Equity
2.49
Cash Flow Metrics
Operating Cash Flow
7.2M
Free Cash Flow
9.9M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2016
Annual Income Flow
2024
Cegedim S.A Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 654.5M | 616.0M | 555.2M | 524.7M | 496.9M |
| Cost of Goods Sold | 95.5M | 87.7M | 81.4M | 84.3M | 73.2M |
| Gross Profit | 559.0M | 528.3M | 473.8M | 440.4M | 423.8M |
| Gross Margin % | 85.4% | 85.8% | 85.3% | 83.9% | 85.3% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 45.5M | 47.0M | 37.7M | 27.3M | 29.9M |
| Other Operating Expenses | 24.0M | 17.1M | 20.1M | 10.9M | 27.4M |
| Total Operating Expenses | 69.4M | 64.0M | 57.9M | 38.2M | 57.3M |
| Operating Income | 25.0M | 23.4M | 14.5M | 37.2M | 24.9M |
| Operating Margin % | 3.8% | 3.8% | 2.6% | 7.1% | 5.0% |
| Non-Operating Items | |||||
| Interest Income | 1.6M | 475.0K | 114.0K | 90.0K | 75.0K |
| Interest Expense | 17.9M | 11.7M | 8.9M | 8.4M | 8.5M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | -9.7M | 8.1M | 17.7M | 33.3M | 13.2M |
| Income Tax | 5.8M | 14.8M | 4.6M | 5.8M | 2.0M |
| Effective Tax Rate % | 0.0% | 183.2% | 26.0% | 17.5% | 14.9% |
| Net Income | -15.1M | -7.9M | 12.1M | 26.3M | 10.9M |
| Net Margin % | -2.3% | -1.3% | 2.2% | 5.0% | 2.2% |
| Key Metrics | |||||
| EBITDA | 118.8M | 109.0M | 115.5M | 107.2M | 104.6M |
| EPS (Basic) | €-1.10 | €-0.50 | €1.00 | €1.90 | €0.80 |
| EPS (Diluted) | €-1.10 | €-0.50 | €1.00 | €1.90 | €0.80 |
| Basic Shares Outstanding | 13706333 | 13610429 | 13658348 | 13782436 | 13824493 |
| Diluted Shares Outstanding | 13706333 | 13610429 | 13658348 | 13782436 | 13824493 |
Income Statement Trend
Cegedim S.A Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 49.6M | 46.6M | 55.6M | 24.2M | 24.7M |
| Short-term Investments | - | - | - | - | 1.0K |
| Accounts Receivable | 186.0M | 175.2M | 151.8M | 136.3M | 134.6M |
| Inventory | 6.7M | 5.5M | 6.5M | 4.5M | 3.8M |
| Other Current Assets | - | - | - | - | - |
| Total Current Assets | 363.1M | 329.1M | 300.4M | 232.7M | 370.5M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 151.7M | 139.0M | 119.7M | 111.5M | 98.3M |
| Goodwill | 662.9M | 593.8M | 585.6M | 554.1M | 535.1M |
| Intangible Assets | 191.4M | 194.2M | 188.1M | 179.9M | 163.0M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | - | 2.0K | 1.0K | - | -1.0K |
| Total Non-Current Assets | 623.8M | 594.9M | 589.5M | 564.9M | 534.9M |
| Total Assets | 986.9M | 924.1M | 889.9M | 797.6M | 905.4M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 71.8M | 61.7M | 55.7M | 48.2M | 43.2M |
| Short-term Debt | 14.1M | 14.8M | 15.9M | 16.1M | 17.8M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 547.0K | 669.0K | 201.0K | 282.0K | 227.0K |
| Total Current Liabilities | 366.2M | 323.1M | 287.1M | 263.7M | 403.3M |
| Non-Current Liabilities | |||||
| Long-term Debt | 77.6M | 78.8M | 75.9M | 70.3M | 248.6M |
| Deferred Tax Liabilities | 1.7M | 5.6M | 6.1M | 8.3M | 7.6M |
| Other Non-Current Liabilities | 1.0K | - | -1.0K | - | 1.0K |
| Total Non-Current Liabilities | 338.2M | 306.4M | 298.7M | 301.5M | 294.1M |
| Total Liabilities | 704.4M | 629.5M | 585.8M | 565.2M | 697.5M |
| Equity | |||||
| Common Stock | 13.4M | 13.3M | 13.3M | 13.3M | 13.3M |
| Retained Earnings | -14.7M | -7.4M | 13.6M | 26.2M | 10.8M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 282.5M | 294.6M | 304.1M | 232.4M | 207.9M |
| Key Metrics | |||||
| Total Debt | 91.8M | 93.6M | 91.8M | 86.4M | 266.5M |
| Working Capital | -3.1M | 6.1M | 13.3M | -31.0M | -32.8M |
Balance Sheet Composition
Cegedim S.A Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -15.1M | -7.9M | 12.1M | 26.3M | 10.9M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | -18.3M | -20.3M | -22.7M | 32.6M | 8.5M |
| Operating Cash Flow | -12.5M | -16.4M | -1.8M | 69.3M | 28.0M |
| Investing Activities | |||||
| Capital Expenditures | -26.3M | -19.4M | -15.5M | 668.0K | 11.0M |
| Acquisitions | -36.9M | -3.4M | 52.5M | -5.1M | -7.1M |
| Investment Purchases | 0 | -1.0M | -2.6M | -3.9M | -1.8M |
| Investment Sales | 934.0K | 805.0K | 1.6M | 2.0M | 40.0K |
| Investing Cash Flow | -58.4M | -22.9M | 35.3M | -6.3M | 2.2M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | - | -6.8M | - | - |
| Debt Issuance | 180.0M | 0 | 0 | 0 | 0 |
| Debt Repayment | -136.4M | -263.0K | -85.0K | -1.2M | -20.2M |
| Financing Cash Flow | 39.4M | -6.2M | -9.8M | -356.0K | -19.1M |
| Free Cash Flow | 11.9M | 22.4M | 10.3M | 45.2M | 55.8M |
| Net Change in Cash | -31.5M | -45.5M | 23.7M | 62.6M | 11.1M |
Cash Flow Trend
Cegedim S.A Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
92.86
Forward P/E
6.84
Price to Book
0.54
Price to Sales
0.22
PEG Ratio
6.84
Profitability Ratios
Profit Margin
-2.25%
Operating Margin
8.56%
Return on Equity
-4.95%
Return on Assets
2.46%
Financial Health
Current Ratio
0.99
Debt to Equity
115.34
Beta
1.02
Per Share Data
EPS (TTM)
€-1.08
Book Value per Share
€19.28
Revenue per Share
€47.75
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| CGM | 188.1M | 92.86 | 0.54 | -4.95% | -2.25% | 115.34 |
| Smaio S.A | 47.0M | 16.30 | 5.78 | -24.00% | -22.35% | 41.76 |
| Abl Diagnostics | 44.4M | 92.00 | 5.94 | 6.73% | 7.44% | 38.66 |
| Intrasense S.A | 11.8M | - | - | -314.39% | -244.82% | -0.21 |
| Media Lab S.p.A | 8.1M | 18.89 | 5.88 | 35.13% | 23.18% | - |
Financial data is updated regularly. All figures are in the company's reporting currency.